Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CLS inks expanded leasing deal at Hamburg property

(Sharecast News) - CLS Holdings announced a significant leasing agreement at its Fangdieckstrasse 75 property in Hamburg on Wednesday, securing over 8,900 square metres of office and laboratory space. The London-listed firm said the Hamburg Institut für Pathologie und Hämatopathologie (HPH), a specialist in diagnosing haematological diseases, had extended its current lease for 5,628 square metres until 2035, and added 3,311 sqm of additional space, bringing its total occupancy to 8,939 square metres.

It said the institute would move into the new space this month, following the departure of the current tenant, ensuring the property remained fully leased.

Fangdieckstrasse 75, acquired by CLS in 2007, had been transformed by the company into a science and healthcare hub.

The building has a total of 13,092 square metres of office, industrial, and laboratory space and is located near the Science City Hamburg Bahrenfeld area - a centre for science and technology start-ups, with excellent transport links.

"We are thrilled that HPH has not only extended their existing lease for over 10 years but has also chosen to lease additional space in Fangdieckstrasse 75," said chief executive officer Fredrik Widlund.

"Hamburg-Bahrenfeld is an up-and-coming commercial area and CLS has successfully repositioned the property as an attractive location for science and technology organisations, and demand from occupiers in this sector remains high."

At 0946 BST, shares in CLS Holdings were up 0.76% at 92.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Bayer shares slump as US court approves review of Monsanto case
(Sharecast News) - Shares in Bayer slumped on Wednesday, after the Washington state Supreme Court said it would review a case alleging that exposure to products of the German chemicals company's Monsanto unit harmed three teachers.
Thames Water creditor group in talks with Ofwat over rescue deal - report
(Sharecast News) - Lenders holding £12bn of Thames Water's debt have reportedly held face-to-face talks with Ofwat this week to pitch a rescue deal that they believe would avert the nationalisation of Britain's biggest water utility.
Berenberg slashes forecasts for Vistry after profit warning
(Sharecast News) - Berenberg has slashed its target price for Vistry by more than a quarter after an unscheduled trading update and profit warning from the housebuilder this week.
RBC Capital upgrades United Utilities, downgrades Pennon
(Sharecast News) - RBC Capital Markets upgraded its stance on United Utilities on Wednesday, but downgraded Pennon as it took a look at UK water stocks.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.